GS
APTO

Gagnon Securities’s Aptose Biosciences, Inc. APTO Stock Holding History

Gagnon Securities’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-170
Closed -$48.9K – 110
2023
Q1 		$48.9K Buy
170
+1
+0.6% +$290 0.01% 110
2022
Q4 		$44K Buy
169
+26
+18% +$6.98K 0.01% 104
2022
Q3 		$38K Buy
143
+28
+24% +$9.65K 0.01% 101
2022
Q2 		$38K Hold
115
– – 0.01% 101
2022
Q1 		$70K Sell
115
-15
-12% -$8.29K 0.01% 103
2021
Q4 		$79K Sell
130
-2
-2% -$1.88K 0.01% 104
2021
Q3 		$129K Sell
132
-111
-46% -$139K 0.02% 111
2021
Q2 		$364K Sell
243
-1
-0.4% -$2.18K 0.05% 90
2021
Q1 		$655K Buy
244
+37
+18% +$73.4K 0.1% 66
2020
Q4 		$408K Buy
207
+20
+11% +$47K 0.07% 73
2020
Q3 		$504K Buy
187
+9
+5% +$22.4K 0.11% 65
2020
Q2 		$506K Buy
+178
New +$574K 0.12% 59
2020
Q1 		– Sell
-124
Closed -$317K – 101
2019
Q4 		$317K Hold
124
– – 0.07% 75
2019
Q3 		$116K Hold
124
– – 0.03% 94
2019
Q2 		$146K Buy
+124
New +$114K 0.03% 93

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Gagnon Securities's APTO Position: Q2 2023 in Review

Gagnon Securities sold out of Aptose Biosciences, Inc. (APTO) in Q2 2023, closing a stake of 170 shares — an estimated $48.9K sold.

Gagnon Securities first reported a position in APTO in Q2 2019 and held it in 15 quarters. The position peaked at $655K in Q1 2021. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.

  • Gagnon Securities reported no remaining Aptose Biosciences, Inc. position as of Q2 2023 after selling out during the quarter.
  • Gagnon Securities sold 170 Aptose Biosciences, Inc. shares in Q2 2023, an estimated $48.9K.
  • Gagnon Securities first reported a position in Aptose Biosciences, Inc. in Q2 2019 and held it in 15 quarters.
  • Gagnon Securities's Aptose Biosciences, Inc. position peaked at $655K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2023.

Based on Gagnon Securities's 13F filing for Q2 2023, filed 8 Aug 2023.